Breteler, Monique M. B.

Plasma Levels of Antioxidants Are Not Associated with Alzheimer’s Disease or Cognitive Decline

Engelhart, M. J., Ruitenberg, A., Meijer, J., Kiliaan, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2005) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 52

SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., et al. (2014) · Human Molecular Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 49

Prognosis of Alzheimer’s Disease: The Rotterdam Study

Ruitenberg, A., Kalmijn, S., de Ridder, M. A. J., Redekop, W. K., van Harskamp, F., Hofman, A., Launer, L. J., & Breteler, M. M. B. (2001) · Neuroepidemiology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 41

Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study

Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology

Dementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 10

O4‐04‐04: TOWARD FINE MAPPING AND FUNCTIONAL CHARACTERIZATION OF GENOME‐WIDE ASSOCIATION STUDY‐IDENTIFIED LOCUS RS74615166 (TRIP4) FOR ALZHEIMER'S DISEASE

Ruiz, A., Heilmann, S., Leber, M., Becker, T., Toliat, M., Royo, J. L., Wagner, H., Thelen, M., Hernandez, I., Alegret, M., et al. (2014) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 1